Acyclovir Injection

Description

Product Description: Acyclovir Injection is a meticulously formulated antiviral medication designed to combat infections caused by herpes viruses effectively. It contains acyclovir, a synthetic nucleoside analogue known for its potent activity against herpes simplex virus (HSV) types 1 and 2, varicella-zoster virus (VZV), and Epstein-Barr virus (EBV). Manufactured to the highest quality standards, this injection offers fast and reliable treatment for herpes infections.

Indications and Usage: Acyclovir Injection is indicated for the treatment of herpes simplex infections, including genital herpes, herpes labialis (cold sores), and herpes keratitis. It is also used in the treatment of herpes zoster (shingles), varicella (chickenpox), and severe Epstein-Barr virus infections in immunocompromised patients.

Dosage and Administration: The dosage of Acyclovir Injection varies depending on the type and severity of the infection, as well as the patient's age and renal function. It is typically administered via intravenous infusion over a specified duration, as determined by the treating healthcare provider. Dosage adjustments may be necessary in patients with impaired renal function.

Dosage Forms and Strengths: Acyclovir Injection is available as a sterile solution in vials containing specific concentrations of acyclovir formulated for parenteral administration. Each vial is carefully manufactured to ensure accurate dosing and optimal therapeutic outcomes.

Contraindications: This product is contraindicated in patients with a known hypersensitivity to acyclovir or any of the excipients. It should not be used in patients with severe renal impairment or in those with a history of neurotoxicity associated with acyclovir therapy. Additionally, it is contraindicated in pregnant women unless the potential benefits outweigh the risks.

Warnings and Precautions: Healthcare providers should exercise caution when prescribing Acyclovir Injection to patients with renal impairment, as accumulation of the drug may lead to increased risk of toxicity. Patients should be monitored regularly for signs of renal dysfunction, neurotoxicity, and hematological abnormalities during therapy.

Adverse Reactions/Side Effects: Common adverse reactions associated with Acyclovir Injection include nausea, vomiting, diarrhea, and headache. Rarely, serious adverse effects such as renal failure, central nervous system toxicity, and allergic reactions may occur. Patients should be advised to report any unusual symptoms promptly.

Drug Interactions: Concomitant use of Acyclovir Injection with nephrotoxic drugs or drugs that compete for renal tubular secretion may increase the risk of renal toxicity or alter the pharmacokinetics of acyclovir. Healthcare providers should review the patient's medication profile carefully to avoid potential drug interactions.

Use In Specific Populations Description: Safety and efficacy of Acyclovir Injection in pediatric patients, pregnant women, and nursing mothers have not been established conclusively. Healthcare providers should assess the potential risks and benefits before prescribing this medication in these populations.

How Supplied/Storage and Handling: Acyclovir Injection is supplied as a sterile solution in vials for parenteral administration. It should be stored at controlled room temperature away from light and moisture. Care should be taken to avoid freezing or excessive heat exposure. Unused portions should be discarded according to standard procedures for biohazardous waste.